Trials / Completed
CompletedNCT00586911
Betaine in Patients With Nonalcoholic Steatohepatitis
A Randomized, Placebo-Controlled Trial of Betaine in Patients With Nonalcoholic Steatohepatitis (NASH)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To assess the safety and efficacy of betaine in patients with NASH on markers of disease severity such as liver histology, liver biochemistries, and health related quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cystadane | Betaine 20 mg a day or identical placebo for 1 year. |
| DRUG | Identical Placebo | Placebo |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2008-01-07
- Last updated
- 2015-04-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00586911. Inclusion in this directory is not an endorsement.